CAS 955085-14-0

Solanezumab

CAS: 955085-14-0

Solanezumab (LY 2062430) is a monoclonal antibody that binds preferentially to soluble amyloid and promotes its clearance from the brain.

Purezza: 96.3% (SDS-PAGE); 97.5% (SEC-HPLC) - 96.3% (SDS-PAGE); 97.5% (SEC-HPLC)

Colore e forma: Liquid

Peso molecolare: 144.07 kDa

Ref: TM-T76827

Solanezumab

CAS: 955085-14-0

Whole humanized monoclonal anitbody targeting Beta amyloid, potential neuroprotector for Alzheimer's disease patients

Ref: 3D-CLA1224